title: Are long-acting insulin analogues better than isophane insulin?
authors.affiliation: Alegent Health Clinic, La Vista, Nebraska, USA. mschooff@alegent.org
authors.forename: Michael D
authors.initials: MD
authors.lastname: Schooff
authors.forename: Lalita
authors.initials: L
authors.lastname: Gupta
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007336:Insulin, Isophane / Q000494:pharmacology / Q000627:therapeutic use*; D049528:Insulin, Long-Acting / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007336:Insulin, Isophane; D049528:Insulin, Long-Acting